AAN: Short-Course IVIG Slows Early Alzheimer's (CME/CE)
SAN DIEGO (MedPage Today) -- Patients with early Alzheimer's disease receiving five doses of intravenous immunoglobulin (IVIG) showed significantly less brain atrophy after one year than a placebo group, researchers said here.
Tags:
AAN: Short-Course IVIG Slows Early Alzheimer's (CME/CE),
Alzheimer's Disease Latest News